StonvexLoading…
StonvexStonvexStonvexCore line items from VATE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $870.50M | $628.30M | $315.20M | $1.42B |
Operating Income | $37.50M | $31.60M | $2.80M | $26.50M |
Net Income | $-18.00M | $-3.00M | $-17.40M | $-35.20M |
EPS (Diluted) | $-1.69 | $-0.35 | $-2.21 | $-4.81 |
Total Assets | $897.20M | $898.90M | $943.50M | $1.04B |
Total Liabilities | $1.02B | $1.01B | $1.08B | $1.18B |
Cash & Equivalents | $51.00M | $80.20M | $38.40M | $80.80M |
Free Cash Flow OCF − CapEx | $-44.10M | $-12.60M | $-31.00M | $8.10M |
Shares Outstanding | 13.17M | 130.53M | 79.89M | 7.92M |